Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy)

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

(2020) Zunyou Wu et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

First imported case of 2019 novel coronavirus in Canada, presenting as mild pneumonia

(2020) William Kyle Silverstein et al.   LANCET

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

(2020) Roujian Lu et al.   LANCET

Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study

(2020) Heshui Shi et al.   LANCET INFECTIOUS DISEASES

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

(2020) Wenhua Liang et al.   LANCET ONCOLOGY

Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors

(2020) Melissa Bersanelli   Immunotherapy

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

(2020) Bin Cao et al.   NEW ENGLAND JOURNAL OF MEDICINE

SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China

(2020) Jing Yu et al.   JAMA Oncology

Myeloid suppressor cells in cancer and autoimmunity

(2017) Antonio Sica et al.   JOURNAL OF AUTOIMMUNITY

Features of Postoperative Immune Suppression Are Reversible With Interferon Gamma and Independent of Interleukin-6 Pathways

(2016) E. Rebecca Longbottom et al.   ANNALS OF SURGERY

Selective Depletion of Regulatory T Cell Subsets by Docetaxel Treatment in Patients with Nonsmall Cell Lung Cancer

(2014) Jie-Yao Li et al.   Journal of Immunology Research

Nosocomial infections in patients with cancer

(2009) Mini Kamboj et al.   LANCET ONCOLOGY